These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6708737)

  • 1. Evaluation of cardiac anoxia and ischemia models in the rat using calcium antagonists.
    Rosenberger LB; Jacobs LW; Stanton HC
    Life Sci; 1984 Apr; 34(14):1379-87. PubMed ID: 6708737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of calcium antagonists on the depletion of cardiac norepinephrine during postischemic reperfusion.
    Nayler WG; Sturrock WJ
    J Cardiovasc Pharmacol; 1985; 7(3):581-7. PubMed ID: 2410693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of ischemic hearts by Ca2+ antagonists.
    Watts JA
    J Mol Cell Cardiol; 1986 Oct; 18 Suppl 4():71-5. PubMed ID: 3491215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of calcium antagonists on energy and substrate metabolism during ischemia and reperfusion in hypertensive myocardial hypertrophy.
    Buser PT; Wagner S; Wu S; Higgins CB; Wikman-Coffelt J
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S87-92. PubMed ID: 1725012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists show two modes of protection in ischemic heart failure.
    van Amsterdam FT; Punt NC; Haas M; Zaagsma J
    J Pharmacol Exp Ther; 1990 Apr; 253(1):277-83. PubMed ID: 2329511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of cardiodepression from cardioprotection with calcium antagonists: diltiazem protects ischemic rat myocardium with a lower functional cost as compared with verapamil or nifedipine.
    Grover GJ; Sleph PG
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):331-40. PubMed ID: 2476610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-channel blockers preserve coronary endothelial reactivity after ischemia-reperfusion.
    Dagenais F; Cartier R; Hollmann C; Buluran J
    Ann Thorac Surg; 1997 Apr; 63(4):1050-6. PubMed ID: 9124904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal differences in actions of calcium channel blockers on K+ accumulation, cardiac function, and high-energy phosphate levels in ischemic guinea pig hearts.
    Sato R; Yamazaki J; Nagao T
    J Pharmacol Exp Ther; 1999 May; 289(2):831-9. PubMed ID: 10215660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nifedipine reduces adenine nucleotide breakdown in ischemic rat heart.
    De Jong JW; Harmsen E; De Tombe PP; Keijzer E
    Eur J Pharmacol; 1982 Jun; 81(1):89-96. PubMed ID: 7117372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium antagonists and myocardial protection during cardioplegic arrest.
    Yamamoto F; Manning AS; Braimbridge MV; Hearse DJ
    Adv Myocardiol; 1985; 6():545-62. PubMed ID: 3992050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amlodipine pretreatment and the ischemic heart.
    Nayler WG
    Am J Cardiol; 1989 Nov; 64(17):65I-69I; discussion 69I-70I. PubMed ID: 2530887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonists and myocardial protection: a comparative study of the functional, metabolic and electrical consequences of verapamil and nifedipine as additives to the St. Thomas' cardioplegic solution.
    Yamamoto F; Manning AS; Crome R; Braimbridge MV; Hearse DJ
    Thorac Cardiovasc Surg; 1985 Dec; 33(6):354-9. PubMed ID: 2417372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nitroglycerin, dipyridamole, nifedipine, verapamil and diltiazem on canine coronary arterial rings contracted with 5-hydroxytryptamine and anoxia.
    Barrett JA; DePaul Lynch V; Balkon J; Smith RD; Wolf PS
    Pharmacology; 1986; 33(3):139-47. PubMed ID: 3092250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of calcium channel inhibitors on the myocardial uptake and retention of technetium 99m N-NOET, a new myocardial perfusion imaging agent: a study on isolated perfused rat hearts.
    Riou L; Ghezzi C; Pasqualini R; Fagret D
    J Nucl Cardiol; 2000; 7(4):365-72. PubMed ID: 10958279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between calcium channel blockers and volatile anaesthetics in the rat heart-lung preparation.
    Kashimoto S; Oguchi T; Kume M; Kumazama T
    Br J Anaesth; 1990 May; 64(5):601-5. PubMed ID: 2354099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of [3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart.
    Zhang WM; Wang HX; Xia Q; Wong TM
    Br J Pharmacol; 1997 Mar; 120(5):827-32. PubMed ID: 9138688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotection with calcium antagonists by suppression of early ischaemia and reperfusion-induced arrhythmias.
    Parratt JR; Coker SJ
    Eur Heart J; 1983 May; 4 Suppl C():49-54. PubMed ID: 6617695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of verapamil on myocardial tolerance to ischemic arrest: comparison to potassium arrest.
    Robb-Nicholson C; Currie WD; Wechsler AS
    Circulation; 1978 Sep; 58(3 Pt 2):I119-24. PubMed ID: 14740691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists and adenine nucleotide metabolism in rat heart.
    Nigdikar SV; Bowditch J; Dow JW
    Cardiovasc Res; 1986 Aug; 20(8):604-8. PubMed ID: 3491685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective aspects of calcium antagonists.
    Nayler WG
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S10-4. PubMed ID: 1725910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.